What are the benefits of anti-tumor necrosis factor–alpha (TNF-alpha) inhibitors in the treatment of toxic epidermal necrolysis (TEN)?

Updated: Jul 01, 2021
  • Author: Samantha P Jellinek-Cohen, PharmD, BCPS (AQ-ID); Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Anti–TNF-α treatment has been reported to rapidly resolve skin lesions due to TEN. TNF-α is strongly expressed in keratinocytes and macrophages of lesional skin, and high concentrations are found in cutaneous blister fluid.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!